AI software could help clinicians diagnose lung cancer earlier and reduce waiting lists for patients

AI software could help clinicians diagnose lung cancer earlier and reduce waiting lists for patients

/ Clinical, News and PR, Partners
A new artificial intelligence software that will help doctors to make quicker and more accurate decisions when diagnosing potentially cancerous ...
Read More
European consortium validates Optellum AI to differentiate between benign and malignant lung nodules in a multi-center study

European consortium validates Optellum AI to differentiate between benign and malignant lung nodules in a multi-center study

A paper published in Lung Cancer demonstrates the ability of Optellum’s Lung Cancer Prediction artificial intelligence (AI) to classify lung ...
Read More
Sam Janes to present to ASCO annual meeting 4-8 June

Sam Janes to present to ASCO annual meeting 4-8 June

Professor Sam Janes, a leading clinician and University College London academic will presenting a poster to American Society of Clinical Oncology (ASCO) annual meeting ...
Read More
Webinar: Dr Vachani and Dr Bellinger discuss AI for lung cancer diagnosis

Webinar: Dr Vachani and Dr Bellinger discuss AI for lung cancer diagnosis

/ Clinical, Event, Partners, Webinar
Join us on June 23rd at 1pm EST for a webinar where expert clinical speakers will discuss the evidence, clinically-validated ...
Read More
NCIMI voices podcast: AI and lung health

NCIMI voices podcast: AI and lung health

The National Consortium of Intelligent Medical Imaging (NCIMI) podcast provides expert insights on the future of #AI in healthcare. In ...
Read More
Optellum in the news

Optellum in the news

/ Media, News and PR, Print, Radio & Podcast, TV, UK
Optellum was in the UK national news this week with coverage from the BBC and the i newspaper, among others ...
Read More
PRESS RELEASE: UK health tech company, goes global with breakthrough in early lung cancer diagnosis AI technology

PRESS RELEASE: UK health tech company, goes global with breakthrough in early lung cancer diagnosis AI technology

Oxford-based company Optellum, supported by NHS collaborations and grant funding, launches the world’s first AI decision support for early lung ...
Read More
Patients and physicians benefit from Optellum’s Virtual Nodule Clinic

Patients and physicians benefit from Optellum’s Virtual Nodule Clinic

/ Clinical, Partners
Optellum is excited to be working with a leading hospital on the first clinical installation of Virtual Nodule Clinic (VNC) ...
Read More
Optellum’s AI could speed up lung cancer screening by detecting benign perifissural lung nodules

Optellum’s AI could speed up lung cancer screening by detecting benign perifissural lung nodules

/ Clinical, News and PR
Optellum has been collaborating with Oxford University Hospitals and UMC Groningen to evaluate the ability of our AI to assist ...
Read More
US PRESS RELEASE: Optellum Receives FDA Clearance for the World’s First AI-Powered Clinical Decision Support Software for Early Lung Cancer Diagnosis

US PRESS RELEASE: Optellum Receives FDA Clearance for the World’s First AI-Powered Clinical Decision Support Software for Early Lung Cancer Diagnosis

/ Clinical, FDA clearance, News and PR, US
Virtual Nodule Clinic empowers clinicians to make optimal clinical decisions in early-stage lung cancer diagnosis and is now commercially available ...
Read More
Optellum named by the UK government as one of the top 100 digital health companies

Optellum named by the UK government as one of the top 100 digital health companies

Healthcare UK, part of the Department for International Trade (DIT), has launched a programme to showcase the UK's leading digital health ...
Read More
Optellum’s year in review

Optellum’s year in review

2020 was an extraordinary year and, looking back, while it was dominated by the world health crisis of the pandemic ...
Read More
Loading...